CVS Health Reports Strong Fourth Quarter And Full Year Profit Growth For 2015; Confirms 2016 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'
February 9, 2016 2:34 PM ESTFBR & Co. reaffirms its Outperform rating and $120 price target on CVS Health (NYSE: CVS) following the retail pharmacy giant's Q4 report earlier Tuesday.
Analyst Steven Halper noted that revenue increased 11 percent and was inline with expectations, as was the company's quarterly... More
Leerink Partners Continues to View CVS Health (CVS) as a High Quality Stock - Reiterates Outperform
February 9, 2016 2:07 PM ESTLeerink Partners reiterated an Outperform rating on CVS Health (NYSE: CVS), and cut the price target to $110.00 (from $125.00), following the company's 4Q earnings report and conference call. On the call management highlighted that total specialty revenue grew +32% y/y, total gross PBM wins... More
